Last reviewed · How we verify

NCT03927469: RSR

Analysis Of The Patients Who Need Rehospitalization Due To Stroke Rehabilitation Only

Completed Last updated 25 April 2019
What this trial tests

trial testing age, sex, hemiplegic side, stroke duration, First hospitalisation duration (day) in Stroke Rehabilitation in 328 participants. Completed in 1 October 2018.

Timeline
15 August 2018
Primary endpoint
1 October 2018
1 October 2018

Quick facts

Lead sponsorIstanbul Physical Medicine Rehabilitation Training and Research Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment328
Start date15 August 2018
Primary completion1 October 2018
Estimated completion1 October 2018
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Istanbul Physical Medicine Rehabilitation Training and Research Hospital

Who can join

Eligibility, any sex, with Stroke Rehabilitation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study was to investigate the clinical and laboratory data of patients who were rehospitalised due to "stroke rehabilitation cause only" The patients who were hospitalized in the hospital between January 2015 and July 2018, according to ICD 10 code; hemiplegia (G81), flaccid hemiplegia (G81.0), hemiplegia, unspecified (G81.9), Spastic hemiplegia (G81.1) scanned from the hospital database.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Stroke Rehabilitation

Currently open trials in the same condition.

Other Istanbul Physical Medicine Rehabilitation Training and Research Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03927469.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing